Clorox Co (NYSE:CLX) shares reached a new 52-week high during mid-day trading on Monday . The stock traded as high as $224.80 and last traded at $221.79, with a volume of 21010 shares traded. The stock had previously closed at $222.16.
Several analysts recently issued reports on CLX shares. JPMorgan Chase & Co. upgraded Clorox from an “underweight” rating to an “overweight” rating and upped their target price for the stock from $153.00 to $185.00 in a report on Monday, March 16th. Cfra upped their price objective on Clorox from $170.00 to $190.00 and gave the company a “hold” rating in a research note on Friday, May 1st. Barclays restated a “sell” rating and issued a $164.00 price objective on shares of Clorox in a research note on Tuesday, May 5th. UBS Group upped their price objective on Clorox from $155.00 to $168.00 and gave the company a “sell” rating in a research note on Monday, May 4th. Finally, DA Davidson initiated coverage on Clorox in a research note on Monday, June 29th. They issued a “buy” rating on the stock. Three analysts have rated the stock with a sell rating, nine have given a hold rating and three have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $173.62.
The firm has a 50-day moving average price of $208.65 and a 200 day moving average price of $181.09. The company has a debt-to-equity ratio of 3.69, a current ratio of 0.98 and a quick ratio of 0.72. The company has a market cap of $27.88 billion, a price-to-earnings ratio of 32.82, a P/E/G ratio of 5.30 and a beta of 0.27.
Clorox (NYSE:CLX) last posted its earnings results on Friday, May 1st. The company reported $1.89 EPS for the quarter, beating the consensus estimate of $1.72 by $0.17. The company had revenue of $1.78 billion for the quarter, compared to the consensus estimate of $1.69 billion. Clorox had a return on equity of 147.52% and a net margin of 13.67%. The firm’s revenue for the quarter was up 15.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.44 earnings per share. On average, equities analysts anticipate that Clorox Co will post 6.91 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Wednesday, July 29th will be given a dividend of $1.11 per share. The ex-dividend date is Tuesday, July 28th. This represents a $4.44 dividend on an annualized basis and a yield of 1.98%. This is an increase from Clorox’s previous quarterly dividend of $1.06. Clorox’s dividend payout ratio is currently 67.09%.
In related news, SVP Denise Garner sold 25,832 shares of the stock in a transaction that occurred on Monday, June 8th. The stock was sold at an average price of $197.62, for a total transaction of $5,104,919.84. Following the sale, the senior vice president now owns 17,468 shares of the company’s stock, valued at $3,452,026.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Kevin B. Jacobsen sold 15,066 shares of the stock in a transaction that occurred on Wednesday, May 13th. The stock was sold at an average price of $206.59, for a total value of $3,112,484.94. Following the sale, the chief financial officer now directly owns 21,452 shares in the company, valued at approximately $4,431,768.68. The disclosure for this sale can be found here. Insiders have sold 73,011 shares of company stock worth $14,788,606 in the last three months. 1.14% of the stock is currently owned by company insiders.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CLX. Marshall Wace North America L.P. bought a new stake in Clorox during the first quarter worth $65,000. Orser Capital Management LLC lifted its stake in Clorox by 6.0% during the fourth quarter. Orser Capital Management LLC now owns 12,010 shares of the company’s stock worth $1,836,000 after purchasing an additional 675 shares during the last quarter. Victory Capital Management Inc. lifted its stake in Clorox by 37.7% during the fourth quarter. Victory Capital Management Inc. now owns 1,542,924 shares of the company’s stock worth $236,901,000 after purchasing an additional 422,479 shares during the last quarter. Franklin Resources Inc. lifted its stake in Clorox by 46.0% during the fourth quarter. Franklin Resources Inc. now owns 128,834 shares of the company’s stock worth $19,779,000 after purchasing an additional 40,595 shares during the last quarter. Finally, Raymond James & Associates lifted its stake in Clorox by 1.4% during the fourth quarter. Raymond James & Associates now owns 219,360 shares of the company’s stock worth $33,683,000 after purchasing an additional 3,126 shares during the last quarter. Hedge funds and other institutional investors own 78.75% of the company’s stock.
Clorox Company Profile (NYSE:CLX)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Recommended Story: How mutual funds make money
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.